Dodge & Cox – BMY history
- Issuer:
- Bristol-Myers Squibb Co.
- Quarters tracked:
- 14 (Q4 2023 → Q1 2026)
- Current shares:
- 4,622,820
- Current value:
- $280.37M
- Peak shares:
- 16,267,041 (Q1 2024)
- Overall change:
- -71%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 4,622,820 | $280.37M | $60.65 | -2,455,430 | -35% |
| Q4 2025 | 7,078,250 | $381.80M | $53.94 | -345,570 | -5% |
| Q3 2025 | 7,423,820 | $334.81M | $45.10 | 0 | 0% |
| Q3 2025 | 7,423,820 | $334.81B | $45100.00 | -1,012,939 | -12% |
| Q2 2025 | 8,436,759 | $390.54M | $46.29 | 0 | 0% |
| Q2 2025 | 8,436,759 | $390.54B | $46290.00 | -4,593,803 | -35% |
| Q1 2025 | 13,030,562 | $794.73M | $60.99 | 0 | 0% |
| Q1 2025 | 13,030,562 | $794.73B | $60990.00 | -2,371,906 | -15% |
| Q4 2024 | 15,402,468 | $871.16B | $56560.00 | 0 | 0% |
| Q4 2024 | 15,402,468 | $871.16M | $56.56 | -225,275 | -1% |
| Q3 2024 | 15,627,743 | $808.58M | $51.74 | -139,155 | -1% |
| Q2 2024 | 15,766,898 | $654.80M | $41.53 | -500,143 | -3% |
| Q1 2024 | 16,267,041 | $882.16M | $54.23 | +66,757 | 0% |
| Q4 2023 | 16,200,284 | $831.24M | $51.31 | — | NEW |